By: Nicole Oran; May 29, 2015 (Featured on MedCityNews)
Johnson & Johnson (NYSE: JNJ) has accepted Cardinal Health‘s $2 billion offer to acquire vascular medical device producer, Cordis.
Teva reached a $1.2 billion settlement with the Federal Trade Commission over claims that Cephalon illegally blocked generics that competed with its sleep-disorder drug Provigil. It marked the first time the FTC had received a financial settlement for drug purchasers in a “pay for delay” case, according to The Wall Street Journal.
In Tech News, Chicago Cardiology Institute has deployed TigerText to accelerate clinician response times…
To read the full article, click here.